Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel: +1 609-9190898
Fax: +1 702-9953905
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
Hua Medicine Reports Positive Phase 1a Data for Novel Glucokinase... 3/19/2014
CDE Review of Class 1 New Drug Applications Nearly Doubled in 201... 3/2/2014
Shanghai Anew Pharma Completes Preclinical Study of Oncology Drug... 3/2/2014
iBio Granted Chinese Patent for HPV-related Cancer Vaccine 2/18/2014
Third Clinical Trial Application for H7N9 Vaccine Filed in China (free) 2/10/2014
Suven Granted Additional Patents in China for Its CNS Drug Candid... 2/4/2014
Sinovac Files Clinical Trial Application for H7N9 Vaccine with CF... (free) 1/29/2014
Takeda Shanghai Initiates Global Phase 3 Trial of Ixazomib 1/28/2014
TCM Found to be Effective against Diabetes as Some Convention Wes... 1/17/2014
EntreMed Files Clinical Trial Application with CFDA for Oncology ... 1/14/2014
Data Snapshot: Indigenously-developed Class I New Drugs 2006-2013... 1/12/2014
Chinese Herbal Medicine Found to Alleviate Inflammatory and Neuro... 1/2/2014
MicuRx Initiates Phase II Trials of Novel Antibiotic in China 12/21/2013
China's First Indigenously-Developed AMD Drug Launched 12/11/2013
Page:2/2    Total number of articles:44  :[1][2]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links